Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PDC-APB
DRUG
2 trials
Sponsors
Hapten Sciences, Inc.
Conditions
Contact Dermatitis
Phase 1
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
Completed
NCT02700373
Hapten Sciences, Inc.
Contact Dermatitis
Start: 2016-03-31
End: 2018-01-31
Updated: 2018-02-23
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
NCT04853823
Hapten Sciences, Inc.
Contact Dermatitis
Start: 2021-11-01
End: 2022-12-01
Target: 32
Updated: 2021-08-27